O-GlcNAc signaling: a metabolic link between diabetes and cancer?

O-linked β-N-acetylglucosamine (O-GlcNAc) is a sugar attachment to serine or threonine hydroxyl moieties on nuclear and cytoplasmic proteins. In many ways, O-GlcNAcylation is similar to phosphorylation because both post-translational modifications cycle rapidly in response to internal or environmental cues. O-GlcNAcylated proteins are involved in transcription, translation, cytoskeletal assembly, signal transduction, and many other cellular functions. O-GlcNAc signaling is intertwined with cellular metabolism; indeed, the donor sugar for O-GlcNAcylation (UDP-GlcNAc) is synthesized from glucose, glutamine, and UTP via the hexosamine biosynthetic pathway. Emerging research indicates that O-GlcNAc signaling and its crosstalk with phosphorylation are altered in metabolic diseases, such as diabetes and cancer.

[1]  T. Kasten,et al.  Kinetic Characterization of Human Glutamine-fructose-6-phosphate Amidotransferase I , 2002, The Journal of Biological Chemistry.

[2]  G. Parker,et al.  Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  W. Yang,et al.  Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability , 2006, Nature Cell Biology.

[4]  G. Hart,et al.  Regulation of Insulin Receptor Substrate 1 (IRS-1)/AKT Kinase-mediated Insulin Signaling by O-Linked β-N-Acetylglucosamine in 3T3-L1 Adipocytes* , 2009, The Journal of Biological Chemistry.

[5]  G. Hart,et al.  Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. , 2008, American journal of physiology. Endocrinology and metabolism.

[6]  G. Hart,et al.  Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase. , 1992, The Journal of biological chemistry.

[7]  I. G. Fantus,et al.  Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Puigserver,et al.  O-GlcNAc Regulates FoxO Activation in Response to Glucose* , 2008, Journal of Biological Chemistry.

[9]  M. Buse,et al.  O-Linked N-Acetylglucosamine Modification of Insulin Receptor Substrate-1 Occurs in Close Proximity to Multiple SH2 Domain Binding Motifs* , 2009, Molecular & Cellular Proteomics.

[10]  G. Sethi,et al.  Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1 , 2010, Oncogene.

[11]  M. Fukuda,et al.  Diabetes and the Accompanying Hyperglycemia Impairs Cardiomyocyte Calcium Cycling through Increased Nuclear O-GlcNAcylation* , 2003, Journal of Biological Chemistry.

[12]  Jonghwan Kim,et al.  Global Identification of Myc Target Genes Reveals Its Direct Role in Mitochondrial Biogenesis and Its E-Box Usage In Vivo , 2008, PloS one.

[13]  E. Newsholme,et al.  The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates. , 1975, The Biochemical journal.

[14]  A. Paterson,et al.  Phosphorylation of Mouse Glutamine-Fructose-6-phosphate Amidotransferase 2 (GFAT2) by cAMP-dependent Protein Kinase Increases the Enzyme Activity* , 2004, Journal of Biological Chemistry.

[15]  A. Wolff,et al.  Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. , 2008, JAMA.

[16]  G. Hart,et al.  Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. , 1984, The Journal of biological chemistry.

[17]  D. Jayne,et al.  Cancer’s craving for sugar: an opportunity for clinical exploitation , 2009, Journal of Cancer Research and Clinical Oncology.

[18]  G. Hart,et al.  AMP-activated Protein Kinase and p38 MAPK Activate O-GlcNAcylation of Neuronal Proteins during Glucose Deprivation* , 2008, Journal of Biological Chemistry.

[19]  G. Hart,et al.  Dynamic O-GlcNAc Modification of Nucleocytoplasmic Proteins in Response to Stress , 2004, Journal of Biological Chemistry.

[20]  G. Hart,et al.  Regulation of Calcium/Calmodulin-dependent Kinase IV by O-GlcNAc Modification* , 2009, The Journal of Biological Chemistry.

[21]  J. Shabanowitz,et al.  Enrichment and Site Mapping of O-Linked N-Acetylglucosamine by a Combination of Chemical/Enzymatic Tagging, Photochemical Cleavage, and Electron Transfer Dissociation Mass Spectrometry* , 2009, Molecular & Cellular Proteomics.

[22]  M. Buse,et al.  Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes. , 2007, American journal of physiology. Endocrinology and metabolism.

[23]  T. Lefebvre,et al.  70-kDa-heat shock protein presents an adjustable lectinic activity towards O-linked N-acetylglucosamine. , 2004, Biochemical and biophysical research communications.

[24]  R. DeFronzo,et al.  Increased Glutamine:Fructose-6-Phosphate Amidotransferase Activity in Skeletal Muscle of Patients With NIDDM , 1996, Diabetes.

[25]  J. Kuromitsu,et al.  cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse. , 1999, Genomics.

[26]  G. Hart,et al.  Ogt-Dependent X-Chromosome-Linked Protein Glycosylation Is a Requisite Modification in Somatic Cell Function and Embryo Viability , 2004, Molecular and Cellular Biology.

[27]  G. Hart,et al.  Dynamic Glycosylation of Nuclear and Cytosolic Proteins , 1997, The Journal of Biological Chemistry.

[28]  J. Hanover,et al.  The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. , 2010, Biochimica et biophysica acta.

[29]  G. Bijur,et al.  Akt1 is dynamically modified with O‐GlcNAc following treatments with PUGNAc and insulin‐like growth factor‐1 , 2006, FEBS letters.

[30]  G. Hart,et al.  A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin. , 2008, Molecular biology of the cell.

[31]  K. Takatsuki,et al.  Hyperammonemia in multiple myeloma. , 1990, Acta haematologica.

[32]  B. Lüscher,et al.  The Ins and Outs of MYC Regulation by Posttranslational Mechanisms* , 2006, Journal of Biological Chemistry.

[33]  G. Sesti,et al.  Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells , 2002, Circulation.

[34]  M. Badet-Denisot,et al.  Identification of a novel serine phosphorylation site in human glutamine:fructose-6-phosphate amidotransferase isoform 1. , 2007, Biochemistry.

[35]  U. Kikkawa,et al.  AMP‐activated protein kinase phosphorylates glutamine : fructose‐6‐phosphate amidotransferase 1 at Ser243 to modulate its enzymatic activity , 2009, Genes to cells : devoted to molecular & cellular mechanisms.

[36]  N. Isern,et al.  c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry , 2009, Oncogene.

[37]  S. Marshall,et al.  Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. , 1991, The Journal of biological chemistry.

[38]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[39]  Zhongjie Sun,et al.  Current views on type 2 diabetes. , 2010, Journal of Endocrinology.

[40]  R. Potter,et al.  Glucosamine-induced increase in Akt phosphorylation corresponds to increased endoplasmic reticulum stress in astroglial cells , 2007, Molecular and Cellular Biochemistry.

[41]  G. Hart,et al.  Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Hart,et al.  Perturbations in O-linked β-N-Acetylglucosamine Protein Modification Cause Severe Defects in Mitotic Progression and Cytokinesis* , 2005, Journal of Biological Chemistry.

[43]  J. Matés,et al.  Antisense glutaminase inhibition modifies the O‐GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells , 2008, Journal of cellular biochemistry.

[44]  J. Hanover,et al.  The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code" , 2005, Science's STKE.

[45]  Jianxin Xie,et al.  Hepatic Glucose Sensing via the CREB Coactivator CRTC2 , 2008, Science.

[46]  G. Hart,et al.  The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  T. Lefebvre,et al.  Identification of Structural and Functional O-Linked N-Acetylglucosamine-bearing Proteins in Xenopus laevis Oocyte*S , 2008, Molecular & Cellular Proteomics.

[48]  M. M. Mc Gee,et al.  Understanding the role of aneuploidy in tumorigenesis. , 2009, Biochemical Society transactions.

[49]  G. Hart,et al.  O-Linked β-N-Acetylglucosaminyltransferase Substrate Specificity Is Regulated by Myosin Phosphatase Targeting and Other Interacting Proteins* , 2008, Journal of Biological Chemistry.

[50]  G. Hart,et al.  The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways , 2010, Journal of Cell Science.

[51]  R. Deberardinis.  Is cancer a disease of abnormal cellular metabolism? New angles on an old idea , 2008, Genetics in Medicine.

[52]  G. Hart,et al.  c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas (*) , 1995, The Journal of Biological Chemistry.

[53]  G. Hart,et al.  Glycosylation of the c-Myc transactivation domain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Dennis,et al.  Increased UDP-GlcNAc:Gal beta 1-3GaLNAc-R (GlcNAc to GaLNAc) beta-1, 6-N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis. , 1991, The Journal of biological chemistry.

[55]  S. Milewski,et al.  Functional domains and interdomain communication in Candida albicans glucosamine-6-phosphate synthase. , 2007, The Biochemical journal.

[56]  Gerald W. Hart,et al.  Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins , 2007, Nature.

[57]  G. Hart,et al.  Cross-talk between GlcNAcylation and phosphorylation: Site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc , 2008, Proceedings of the National Academy of Sciences.

[58]  J. Foker,et al.  Aerobic glycolysis during lymphocyte proliferation , 1976, Nature.

[59]  M. Buse,et al.  Identification of the Major Site of O-Linked β-N-Acetylglucosamine Modification in the C Terminus of Insulin Receptor Substrate-1 *S , 2006, Molecular & Cellular Proteomics.

[60]  P. Puigserver,et al.  A PGC-1α-O-GlcNAc Transferase Complex Regulates FoxO Transcription Factor Activity in Response to Glucose* , 2009, Journal of Biological Chemistry.

[61]  Chi V Dang,et al.  Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. , 2010, Cancer research.

[62]  G. Hart,et al.  Regulation of a Cytosolic and Nuclear O-GlcNAc Transferase , 1999, The Journal of Biological Chemistry.

[63]  V. Mohan,et al.  Glutamine fructose-6-phosphate amidotransferase (GFAT) gene expression and activity in patients with type 2 diabetes: inter-relationships with hyperglycaemia and oxidative stress. , 2007, Clinical biochemistry.

[64]  G. Parker,et al.  Chronic Hexosamine Flux Stimulates Fatty Acid Oxidation by Activating AMP-activated Protein Kinase in Adipocytes* , 2007, Journal of Biological Chemistry.

[65]  D. Hardie.  Role of AMP‐activated protein kinase in the metabolic syndrome and in heart disease , 2008, FEBS letters.

[66]  Xiaoyong Yang,et al.  Phosphorylation of Human Glutamine:Fructose-6-phosphate Amidotransferase by cAMP-dependent Protein Kinase at Serine 205 Blocks the Enzyme Activity* , 2000, The Journal of Biological Chemistry.

[67]  R. Duggirala,et al.  A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans. , 2005, Diabetes.

[68]  H. Eagle,et al.  The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid. , 1956, The Journal of biological chemistry.

[69]  A. Tanigami,et al.  Identification of GFAT1-L, a novel splice variant of human glutamine: fructose-6-phosphate amidotransferase (GFAT1) that is expressed abundantly in skeletal muscle , 2001, Journal of Human Genetics.

[70]  J. Shabanowitz,et al.  Extensive Crosstalk Between O-GlcNAcylation and Phosphorylation Regulates Cytokinesis , 2010, Science Signaling.

[71]  S. Ferrari,et al.  Protein kinases controlling the onset of mitosis , 2006, Cellular and Molecular Life Sciences CMLS.

[72]  Jürgen Roth,et al.  O-GlcNAc Protein Modification in Cancer Cells Increases in Response to Glucose Deprivation through Glycogen Degradation* , 2009, The Journal of Biological Chemistry.

[73]  Seung-Yoon Park,et al.  O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes , 2005, Experimental & Molecular Medicine.

[74]  G. Hart,et al.  Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. , 2007, Nature.

[75]  M. Lagarde,et al.  Hyperglycemia and glucosamine‐induced mesangial cell cycle arrest and hypertrophy: Common or independent mechanisms? , 2006, IUBMB life.

[76]  R. Potter,et al.  Increased N-acetyl-beta-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins. , 2001, Biochimica et biophysica acta.

[77]  A. Pandey,et al.  O-Linked N-Acetylglucosamine Modification on CCAAT Enhancer-binding Protein β , 2009, The Journal of Biological Chemistry.

[78]  G. Hart,et al.  Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. , 2002, The Journal of biological chemistry.

[79]  C. Sweep,et al.  Hexosamines are unlikely to function as a nutrient-sensor in 3T3-L1 adipocytes , 2004, Endocrine.

[80]  Ralph J Deberardinis,et al.  Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.

[81]  G. Hart,et al.  Regulation of the O-Linked β-N-Acetylglucosamine Transferase by Insulin Signaling* , 2008, Journal of Biological Chemistry.

[82]  H. Heimberg,et al.  Glucosamine-induced Insulin Resistance in 3T3-L1 Adipocytes Is Caused by Depletion of Intracellular ATP* , 1998, The Journal of Biological Chemistry.

[83]  V. Raia,et al.  Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. , 2010, The Journal of clinical investigation.

[84]  S. Marshall,et al.  Dynamic Actions of Glucose and Glucosamine on Hexosamine Biosynthesis in Isolated Adipocytes , 2004, Journal of Biological Chemistry.

[85]  W. V. So,et al.  Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance , 2008, Nature.

[86]  G. Davies,et al.  Elevation of Global O-GlcNAc Levels in 3T3-L1 Adipocytes by Selective Inhibition of O-GlcNAcase Does Not Induce Insulin Resistance* , 2008, Journal of Biological Chemistry.